B. Riley analyst Kyle Bauser lowered the firm’s price target on Performant Financial (PFMT) to $7 from $8 and keeps a Buy rating on the shares post the Q3 report. The company reiterated fiscal 2024 healthcare sales and adjusted EBITDA guidance while reducing nonhealthcare sales expectations, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFMT: